EGFR and non-small cell lung carcinoma: The in-depth research and clinical use of epidermal growth factor receptor (EGFR) and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) have provided a dawn for the treatment of advanced NSCLC.